Table 3. Correlation between miR-564 expression and clinicopathological characteristics in 46 patients with HCC.
| Characteristics | n | miR-564 expression | p-values | |
|---|---|---|---|---|
| High | low | |||
| All case | 46 | 23 | 23 | |
| Gender | 0.32 | |||
| Male | 33 | 15 (45.5%) | 18 (54.5%) | |
| Female | 13 | 8 (61.5%) | 5 (38.5%) | |
| Age | 0.76 | |||
| ≥60 | 17 | 8 (47.1%) | 9 (52.9%) | |
| <60 | 29 | 15 (51.7%) | 14 (48.3%) | |
| HBsAg | 0.32 | |||
| Positive | 33 | 15 (45.5%) | 18 (54.5%) | |
| Negative | 13 | 8 (61.5%) | 5 (38.4%) | |
| Tumor size (cm) | 0.001 | |||
| ≥5 | 21 | 5 (23.8%) | 16 (76.2%) | |
| <5 | 25 | 18 (72.0%) | 7 (28.0%) | |
| Tumor number | 0.044 | |||
| Single | 34 | 20 (58.8%) | 14 (41.2%) | |
| Multiple | 12 | 3 (25.0%) | 9 (75.0%) | |
| Differentiation | 0.14 | |||
| High | 25 | 15 (60.0%) | 10 (40.0%) | |
| Low | 21 | 8 (38.1%) | 13 (61.9%) | |
| Vein invasion | 0.003 | |||
| Yes | 20 | 5 (25.0%) | 15 (75.0%) | |
| No | 26 | 18 (69.2%) | 8 (30.8%) | |
| AFP(ng/ml) | 0.47 | |||
| >400 | 10 | 4 (40.0%) | 6 (60.0%) | |
| ≤400 | 36 | 19 (52.8%) | 17 (47.2%) | |
| TNM stage | 0.077 | |||
| I–II | 24 | 15 (62.5%) | 9 (37.5%) | |
| III–IV | 22 | 8 (36.4%) | 14 (63.6%) | |